SLC1A2 and early-onset autosomal dominant Alzheimer disease: Alzheimer's disease (AD) is characterized by glutamatergic dysregulation and excitotoxicity, largely associated with impaired activity of the excitatory amino acid transporter 2 (EAAT2).